Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 96

1.

Leptospirosis in Indonesia: diagnostic challenges associated with atypical clinical manifestations and limited laboratory capacity.

Gasem MH, Hadi U, Alisjahbana B, Tjitra E, Hapsari MMDEAH, Lestari ES, Aman AT, Lokida D, Salim G, Kosasih H, Merati KTP, Laras K, Arif M, Lukman N, Sudarmono P, Lisdawati V, Lau CY, Neal A, Karyana M.

BMC Infect Dis. 2020 Feb 27;20(1):179. doi: 10.1186/s12879-020-4903-5.

2.

An observational prospective cohort study of the epidemiology of hospitalized patients with acute febrile illness in Indonesia.

Gasem MH, Kosasih H, Tjitra E, Alisjahbana B, Karyana M, Lokida D, Neal A, Liang CJ, Aman AT, Arif M, Sudarmono P, Suharto, Merati TP, Lisdawati V, Siswanto, Siddiqui S, Lane HC; for INA-RESPOND.

PLoS Negl Trop Dis. 2020 Jan 10;14(1):e0007927. doi: 10.1371/journal.pntd.0007927. eCollection 2020 Jan.

3.

Treatment-seeking behaviour and associated costs for malaria in Papua, Indonesia.

Karyana M, Devine A, Kenangalem E, Burdarm L, Poespoprodjo JR, Vemuri R, Anstey NM, Tjitra E, Price RN, Yeung S.

Malar J. 2016 Nov 8;15(1):536.

4.

Plasmodium vivax infection: a major determinant of severe anaemia in infancy.

Kenangalem E, Karyana M, Burdarm L, Yeung S, Simpson JA, Tjitra E, Anstey NM, Poespoprodjo JR, Price RN, Douglas NM.

Malar J. 2016 Jun 16;15:321. doi: 10.1186/s12936-016-1373-8.

5.

INA-RESPOND: a multi-centre clinical research network in Indonesia.

Karyana M, Kosasih H, Samaan G, Tjitra E, Aman AT, Alisjahbana B, Fatmawati, Gasem MH, Arif M, Sudarmono P, Suharto, Merati TP, Lane C, Siswanto, Siddiqui S.

Health Res Policy Syst. 2015 Jul 29;13:34. doi: 10.1186/s12961-015-0024-9.

6.

Treatment policy change to dihydroartemisinin-piperaquine contributes to the reduction of adverse maternal and pregnancy outcomes.

Poespoprodjo JR, Fobia W, Kenangalem E, Lampah DA, Sugiarto P, Tjitra E, Anstey NM, Price RN.

Malar J. 2015 Jul 15;14:272. doi: 10.1186/s12936-015-0794-0.

7.

The effect of dosing strategies on the therapeutic efficacy of artesunate-amodiaquine for uncomplicated malaria: a meta-analysis of individual patient data.

WorldWide Antimalarial Resistance Network (WWARN) AS-AQ Study Group, Adjuik MA, Allan R, Anvikar AR, Ashley EA, Ba MS, Barennes H, Barnes KI, Bassat Q, Baudin E, Björkman A, Bompart F, Bonnet M, Borrmann S, Brasseur P, Bukirwa H, Checchi F, Cot M, Dahal P, D'Alessandro U, Deloron P, Desai M, Diap G, Djimde AA, Dorsey G, Doumbo OK, Espié E, Etard JF, Fanello CI, Faucher JF, Faye B, Flegg JA, Gaye O, Gething PW, González R, Grandesso F, Guerin PJ, Guthmann JP, Hamour S, Hasugian AR, Hay SI, Humphreys GS, Jullien V, Juma E, Kamya MR, Karema C, Kiechel JR, Kremsner PG, Krishna S, Lameyre V, Ibrahim LM, Lee SJ, Lell B, Mårtensson A, Massougbodji A, Menan H, Ménard D, Menéndez C, Meremikwu M, Moreira C, Nabasumba C, Nambozi M, Ndiaye JL, Nikiema F, Nsanzabana C, Ntoumi F, Ogutu BR, Olliaro P, Osorio L, Ouédraogo JB, Penali LK, Pene M, Pinoges L, Piola P, Price RN, Roper C, Rosenthal PJ, Rwagacondo CE, Same-Ekobo A, Schramm B, Seck A, Sharma B, Sibley CH, Sinou V, Sirima SB, Smith JJ, Smithuis F, Somé FA, Sow D, Staedke SG, Stepniewska K, Swarthout TD, Sylla K, Talisuna AO, Tarning J, Taylor WR, Temu EA, Thwing JI, Tjitra E, Tine RC, Tinto H, Vaillant MT, Valecha N, Van den Broek I, White NJ, Yeka A, Zongo I.

BMC Med. 2015 Mar 31;13:66. doi: 10.1186/s12916-015-0301-z.

8.

Impaired systemic tetrahydrobiopterin bioavailability and increased dihydrobiopterin in adult falciparum malaria: association with disease severity, impaired microvascular function and increased endothelial activation.

Yeo TW, Lampah DA, Kenangalem E, Tjitra E, Price RN, Weinberg JB, Hyland K, Granger DL, Anstey NM.

PLoS Pathog. 2015 Mar 12;11(3):e1004667. doi: 10.1371/journal.ppat.1004667. eCollection 2015 Mar.

9.

Decreased endothelial nitric oxide bioavailability, impaired microvascular function, and increased tissue oxygen consumption in children with falciparum malaria.

Yeo TW, Lampah DA, Kenangalem E, Tjitra E, Weinberg JB, Granger DL, Price RN, Anstey NM.

J Infect Dis. 2014 Nov 15;210(10):1627-32. doi: 10.1093/infdis/jiu308. Epub 2014 May 30.

10.

Rapid clinical assessment to facilitate the triage of adults with falciparum malaria, a retrospective analysis.

Hanson J, Lee SJ, Mohanty S, Faiz MA, Anstey NM, Price RN, Charunwatthana P, Yunus EB, Mishra SK, Tjitra E, Rahman R, Nosten F, Htut Y, Maude RJ, Chau TT, Phu NH, Hien TT, White NJ, Day NP, Dondorp AM.

PLoS One. 2014 Jan 29;9(1):e87020. doi: 10.1371/journal.pone.0087020. eCollection 2014.

11.

Dihydroartemisinin-piperaquine treatment of multidrug resistant falciparum and vivax malaria in pregnancy.

Poespoprodjo JR, Fobia W, Kenangalem E, Lampah DA, Sugiarto P, Tjitra E, Anstey NM, Price RN.

PLoS One. 2014 Jan 17;9(1):e84976. doi: 10.1371/journal.pone.0084976. eCollection 2014.

12.

High morbidity during treatment and residual pulmonary disability in pulmonary tuberculosis: under-recognised phenomena.

Ralph AP, Kenangalem E, Waramori G, Pontororing GJ, Sandjaja, Tjitra E, Maguire GP, Kelly PM, Anstey NM.

PLoS One. 2013 Nov 29;8(11):e80302. doi: 10.1371/journal.pone.0080302. eCollection 2013.

13.

Tuberculosis outcomes in Papua, Indonesia: the relationship with different body mass index characteristics between papuan and non-Papuan ethnic groups.

Kenangalem E, Waramori G, Pontororing GJ, Sandjaja, Tjitra E, Maguire G, Kelly PM, Anstey NM, Ralph AP.

PLoS One. 2013 Sep 27;8(9):e76077. doi: 10.1371/journal.pone.0076077. eCollection 2013.

14.

L-arginine and vitamin D adjunctive therapies in pulmonary tuberculosis: a randomised, double-blind, placebo-controlled trial.

Ralph AP, Waramori G, Pontororing GJ, Kenangalem E, Wiguna A, Tjitra E, Sandjaja, Lolong DB, Yeo TW, Chatfield MD, Soemanto RK, Bastian I, Lumb R, Maguire GP, Eisman J, Price RN, Morris PS, Kelly PM, Anstey NM.

PLoS One. 2013 Aug 14;8(8):e70032. doi: 10.1371/journal.pone.0070032. eCollection 2013.

15.

A randomized comparison of dihydroartemisinin-piperaquine and artesunate-amodiaquine combined with primaquine for radical treatment of vivax malaria in Sumatera, Indonesia.

Pasaribu AP, Chokejindachai W, Sirivichayakul C, Tanomsing N, Chavez I, Tjitra E, Pasaribu S, Imwong M, White NJ, Dondorp AM.

J Infect Dis. 2013 Dec 1;208(11):1906-13. doi: 10.1093/infdis/jit407. Epub 2013 Aug 6.

16.

A randomized pilot study of L-arginine infusion in severe falciparum malaria: preliminary safety, efficacy and pharmacokinetics.

Yeo TW, Lampah DA, Rooslamiati I, Gitawati R, Tjitra E, Kenangalem E, Price RN, Duffull SB, Anstey NM.

PLoS One. 2013 Jul 29;8(7):e69587. doi: 10.1371/journal.pone.0069587. Print 2013.

17.

Increased carboxyhemoglobin in adult falciparum malaria is associated with disease severity and mortality.

Yeo TW, Lampah DA, Kenangalem E, Tjitra E, Price RN, Anstey NM.

J Infect Dis. 2013 Sep 1;208(5):813-7. doi: 10.1093/infdis/jit253. Epub 2013 Jul 12.

18.

Haemoglobin dynamics in Papuan and non-Papuan adults in northeast Papua, Indonesia, with acute, uncomplicated vivax or falciparum malaria.

Taylor WR, Widjaja H, Basri H, Tjitra E, Ohrt C, Taufik T, Baso S, Hoffman SL, Richie TL.

Malar J. 2013 Jun 19;12:209. doi: 10.1186/1475-2875-12-209.

19.

Gametocyte dynamics and the role of drugs in reducing the transmission potential of Plasmodium vivax.

Douglas NM, Simpson JA, Phyo AP, Siswantoro H, Hasugian AR, Kenangalem E, Poespoprodjo JR, Singhasivanon P, Anstey NM, White NJ, Tjitra E, Nosten F, Price RN.

J Infect Dis. 2013 Sep 1;208(5):801-12. doi: 10.1093/infdis/jit261. Epub 2013 Jun 12.

20.

Impaired pulmonary nitric oxide bioavailability in pulmonary tuberculosis: association with disease severity and delayed mycobacterial clearance with treatment.

Ralph AP, Yeo TW, Salome CM, Waramori G, Pontororing GJ, Kenangalem E, Sandjaja, Tjitra E, Lumb R, Maguire GP, Price RN, Chatfield MD, Kelly PM, Anstey NM.

J Infect Dis. 2013 Aug 15;208(4):616-26. doi: 10.1093/infdis/jit248. Epub 2013 Jun 3.

21.

Impaired skeletal muscle microvascular function and increased skeletal muscle oxygen consumption in severe falciparum malaria.

Yeo TW, Lampah DA, Kenangalem E, Tjitra E, Price RN, Anstey NM.

J Infect Dis. 2013 Feb 1;207(3):528-36. doi: 10.1093/infdis/jis692. Epub 2012 Nov 16.

22.

Efficacy and safety of artemisinin-naphthoquine versus dihydroartemisinin-piperaquine in adult patients with uncomplicated malaria: a multi-centre study in Indonesia.

Tjitra E, Hasugian AR, Siswantoro H, Prasetyorini B, Ekowatiningsih R, Yusnita EA, Purnamasari T, Driyah S, Salwati E; Nurhayati, Yuwarni E, Januar L, Labora J, Wijayanto B, Amansyah F, Dedang TA, Purnama A; Trihono.

Malar J. 2012 Jun 14;11:153. doi: 10.1186/1475-2875-11-153.

23.

Highly effective therapy for maternal malaria associated with a lower risk of vertical transmission.

Poespoprodjo JR, Fobia W, Kenangalem E, Hasanuddin A, Sugiarto P, Tjitra E, Anstey NM, Price RN.

J Infect Dis. 2011 Nov 15;204(10):1613-9. doi: 10.1093/infdis/jir558. Epub 2011 Sep 9.

24.

Ex vivo drug susceptibility of ferroquine against chloroquine-resistant isolates of Plasmodium falciparum and P. vivax.

Marfurt J, Chalfein F, Prayoga P, Wabiser F, Kenangalem E, Piera KA, Machunter B, Tjitra E, Anstey NM, Price RN.

Antimicrob Agents Chemother. 2011 Sep;55(9):4461-4. doi: 10.1128/AAC.01375-10. Epub 2011 Jul 5.

25.

Coma associated with microscopy-diagnosed Plasmodium vivax: a prospective study in Papua, Indonesia.

Lampah DA, Yeo TW, Hardianto SO, Tjitra E, Kenangalem E, Sugiarto P, Price RN, Anstey NM.

PLoS Negl Trop Dis. 2011 Jun;5(6):e1032. doi: 10.1371/journal.pntd.0001032. Epub 2011 Jun 7.

26.

The burden and treatment of HIV in tuberculosis patients in Papua Province, Indonesia: a prospective observational study.

Pontororing GJ, Kenangalem E, Lolong DB, Waramori G, Sandjaja, Tjitra E, Price RN, Kelly PM, Anstey NM, Ralph AP.

BMC Infect Dis. 2010;10:362. doi: 10.1186/1471-2334-10-362. Epub 2010 Dec 24.

27.

Differential cellular recognition of antigens during acute Plasmodium falciparum and Plasmodium vivax malaria.

Salwati E, Minigo G, Woodberry T, Piera KA, de Silva HD, Kenangalem E, Tjitra E, Coppel RL, Price RN, Anstey NM, Plebanski M.

J Infect Dis. 2011 Apr 15;203(8):1192-1199. doi: 10.1093/infdis/jiq166.

28.

Pyronaridine-artesunate versus chloroquine in patients with acute Plasmodium vivax malaria: a randomized, double-blind, non-inferiority trial.

Poravuth Y, Socheat D, Rueangweerayut R, Uthaisin C, Pyae Phyo A, Valecha N, Rao BH, Tjitra E, Purnama A, Borghini-Fuhrer I, Duparc S, Shin CS, Fleckenstein L.

PLoS One. 2011 Jan 18;6(1):e14501. doi: 10.1371/journal.pone.0014501.

29.

Ex vivo activity of histone deacetylase inhibitors against multidrug-resistant clinical isolates of Plasmodium falciparum and P. vivax.

Marfurt J, Chalfein F, Prayoga P, Wabiser F, Kenangalem E, Piera KA, Fairlie DP, Tjitra E, Anstey NM, Andrews KT, Price RN.

Antimicrob Agents Chemother. 2011 Mar;55(3):961-6. doi: 10.1128/AAC.01220-10. Epub 2010 Dec 6.

30.

A study of the TNF/LTA/LTB locus and susceptibility to severe malaria in highland papuan children and adults.

Randall LM, Kenangalem E, Lampah DA, Tjitra E, Mwaikambo ED, Handojo T, Piera KA, Zhao ZZ, de Labastida Rivera F, Zhou Y, McSweeney KM, Le L, Amante FH, Haque A, Stanley AC, Woodberry T, Salwati E, Granger DL, Hobbs MR, Price RN, Weinberg JB, Montgomery GW, Anstey NM, Engwerda CR.

Malar J. 2010 Oct 29;9:302. doi: 10.1186/1475-2875-9-302.

31.

In vivo and in vitro efficacy of chloroquine against Plasmodium malariae and P. ovale in Papua, Indonesia.

Siswantoro H, Russell B, Ratcliff A, Prasetyorini B, Chalfein F, Marfurt J, Kenangalem E, Wuwung M, Piera KA, Ebsworth EP, Anstey NM, Tjitra E, Price RN.

Antimicrob Agents Chemother. 2011 Jan;55(1):197-202. doi: 10.1128/AAC.01122-10. Epub 2010 Oct 11.

32.

In vitro activity of pyronaridine against multidrug-resistant Plasmodium falciparum and Plasmodium vivax.

Price RN, Marfurt J, Chalfein F, Kenangalem E, Piera KA, Tjitra E, Anstey NM, Russell B.

Antimicrob Agents Chemother. 2010 Dec;54(12):5146-50. doi: 10.1128/AAC.00801-10. Epub 2010 Sep 27.

33.

A simple, valid, numerical score for grading chest x-ray severity in adult smear-positive pulmonary tuberculosis.

Ralph AP, Ardian M, Wiguna A, Maguire GP, Becker NG, Drogumuller G, Wilks MJ, Waramori G, Tjitra E, Sandjaja, Kenagalem E, Pontororing GJ, Anstey NM, Kelly PM.

Thorax. 2010 Oct;65(10):863-9. doi: 10.1136/thx.2010.136242.

PMID:
20861290
34.

Age-related susceptibility to severe malaria associated with galectin-2 in highland Papuans.

Randall LM, Kenangalem E, Lampah DA, Tjitra E, Mwaikambo ED, Handojo T, Piera KA, Zhao ZZ, de Labastida Rivera F, Zhou Y, McSweeney KM, Le L, Amante FH, Haque A, Stanley AC, Woodberry T, Salwati E, Granger DL, Hobbs MR, Price RN, Weinberg JB, Montgomery GW, Anstey NM, Engwerda CR.

J Infect Dis. 2010 Jul 1;202(1):117-24. doi: 10.1086/653125.

35.

Greater endothelial activation, Weibel-Palade body release and host inflammatory response to Plasmodium vivax, compared with Plasmodium falciparum: a prospective study in Papua, Indonesia.

Yeo TW, Lampah DA, Tjitra E, Piera K, Gitawati R, Kenangalem E, Price RN, Anstey NM.

J Infect Dis. 2010 Jul 1;202(1):109-12. doi: 10.1086/653211.

36.

Increased asymmetric dimethylarginine in severe falciparum malaria: association with impaired nitric oxide bioavailability and fatal outcome.

Yeo TW, Lampah DA, Tjitra E, Gitawati R, Darcy CJ, Jones C, Kenangalem E, McNeil YR, Granger DL, Lopansri BK, Weinberg JB, Price RN, Duffull SB, Celermajer DS, Anstey NM.

PLoS Pathog. 2010 Apr 22;6(4):e1000868. doi: 10.1371/journal.ppat.1000868. Erratum in: PLoS Pathog. 2010;6(5). doi: 10.1371/annotation/e49842d3-ea72-45a4-93d4-2f494baee962.

37.

Efficacy and safety of a fixed-dose oral combination of pyronaridine-artesunate compared with artemether-lumefantrine in children and adults with uncomplicated Plasmodium falciparum malaria: a randomised non-inferiority trial.

Tshefu AK, Gaye O, Kayentao K, Thompson R, Bhatt KM, Sesay SS, Bustos DG, Tjitra E, Bedu-Addo G, Borghini-Fuhrer I, Duparc S, Shin CS, Fleckenstein L; Pyronaridine-artesunate Study Team.

Lancet. 2010 Apr 24;375(9724):1457-67. doi: 10.1016/S0140-6736(10)60322-4.

PMID:
20417857
38.

Severe congenital malaria acquired in utero.

Poespoprodjo JR, Hasanuddin A, Fobia W, Sugiarto P, Kenangalem E, Lampah DA, Tjitra E, Price RN, Anstey NM.

Am J Trop Med Hyg. 2010 Apr;82(4):563-5. doi: 10.4269/ajtmh.2010.09-0744.

39.

A simple score to predict the outcome of severe malaria in adults.

Hanson J, Lee SJ, Mohanty S, Faiz MA, Anstey NM, Charunwatthana P, Yunus EB, Mishra SK, Tjitra E, Price RN, Rahman R, Nosten F, Htut Y, Hoque G, Hong Chau TT, Hoan Phu N, Hien TT, White NJ, Day NP, Dondorp AM.

Clin Infect Dis. 2010 Mar 1;50(5):679-85. doi: 10.1086/649928.

40.

Pulmonary tuberculosis, impaired lung function, disability and quality of life in a high-burden setting.

Maguire GP, Anstey NM, Ardian M, Waramori G, Tjitra E, Kenangalem E, Handojo T, Kelly PM.

Int J Tuberc Lung Dis. 2009 Dec;13(12):1500-6.

PMID:
19919767
41.

Relationship of cell-free hemoglobin to impaired endothelial nitric oxide bioavailability and perfusion in severe falciparum malaria.

Yeo TW, Lampah DA, Tjitra E, Gitawati R, Kenangalem E, Piera K, Granger DL, Lopansri BK, Weinberg JB, Price RN, Duffull SB, Celermajer DS, Anstey NM.

J Infect Dis. 2009 Nov 15;200(10):1522-9. doi: 10.1086/644641.

42.

Human T cell recognition of the blood stage antigen Plasmodium hypoxanthine guanine xanthine phosphoribosyl transferase (HGXPRT) in acute malaria.

Woodberry T, Pinzon-Charry A, Piera KA, Panpisutchai Y, Engwerda CR, Doolan DL, Salwati E, Kenangalem E, Tjitra E, Price RN, Good MF, Anstey NM.

Malar J. 2009 Jun 7;8:122. doi: 10.1186/1475-2875-8-122.

43.

Vivax malaria: a major cause of morbidity in early infancy.

Poespoprodjo JR, Fobia W, Kenangalem E, Lampah DA, Hasanuddin A, Warikar N, Sugiarto P, Tjitra E, Anstey NM, Price RN.

Clin Infect Dis. 2009 Jun 15;48(12):1704-12. doi: 10.1086/599041.

44.

Parasite-dependent expansion of TNF receptor II-positive regulatory T cells with enhanced suppressive activity in adults with severe malaria.

Minigo G, Woodberry T, Piera KA, Salwati E, Tjitra E, Kenangalem E, Price RN, Engwerda CR, Anstey NM, Plebanski M.

PLoS Pathog. 2009 Apr;5(4):e1000402. doi: 10.1371/journal.ppat.1000402. Epub 2009 Apr 24.

45.

Cost-effectiveness of artesunate for the treatment of severe malaria.

Lubell Y, Yeung S, Dondorp AM, Day NP, Nosten F, Tjitra E, Abul Faiz M, Yunus EB, Anstey NM, Mishra SK, Mohanty S, White NJ, Mills AJ.

Trop Med Int Health. 2009 Mar;14(3):332-7. doi: 10.1111/j.1365-3156.2009.02227.x. Epub 2009 Jan 28.

46.

In vivo and in vitro efficacy of amodiaquine monotherapy for treatment of infection by chloroquine-resistant Plasmodium vivax.

Hasugian AR, Tjitra E, Ratcliff A, Siswantoro H, Kenangalem E, Wuwung RM, Purba HL, Piera KA, Chalfien F, Marfurt J, Penttinen PM, Russell B, Anstey NM, Price RN.

Antimicrob Agents Chemother. 2009 Mar;53(3):1094-9. doi: 10.1128/AAC.01511-08. Epub 2008 Dec 22.

47.

Changes in the total leukocyte and platelet counts in Papuan and non Papuan adults from northeast Papua infected with acute Plasmodium vivax or uncomplicated Plasmodium falciparum malaria.

Taylor WR, Widjaja H, Basri H, Ohrt C, Taufik T, Tjitra E, Baso S, Fryauff D, Hoffman SL, Richie TL.

Malar J. 2008 Dec 18;7:259. doi: 10.1186/1475-2875-7-259.

48.

High deformability of Plasmodium vivax-infected red blood cells under microfluidic conditions.

Handayani S, Chiu DT, Tjitra E, Kuo JS, Lampah D, Kenangalem E, Renia L, Snounou G, Price RN, Anstey NM, Russell B.

J Infect Dis. 2009 Feb 1;199(3):445-50. doi: 10.1086/596048.

49.

Angiopoietin-2 is associated with decreased endothelial nitric oxide and poor clinical outcome in severe falciparum malaria.

Yeo TW, Lampah DA, Gitawati R, Tjitra E, Kenangalem E, Piera K, Price RN, Duffull SB, Celermajer DS, Anstey NM.

Proc Natl Acad Sci U S A. 2008 Nov 4;105(44):17097-102. doi: 10.1073/pnas.0805782105. Epub 2008 Oct 28.

50.

Pharmacokinetics of L-arginine in adults with moderately severe malaria.

Yeo TW, Rooslamiati I, Gitawati R, Tjitra E, Lampah DA, Kenangalem E, McNeil YR, Price RN, Anstey NM, Duffull SB.

Antimicrob Agents Chemother. 2008 Dec;52(12):4381-7. doi: 10.1128/AAC.00421-08. Epub 2008 Oct 6.

Supplemental Content

Loading ...
Support Center